{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T03:53:29Z","timestamp":1766030009665,"version":"3.48.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,17]]},"DOI":"10.7759\/cureus.99496","type":"journal-article","created":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T03:45:47Z","timestamp":1766029547000},"source":"Crossref","is-referenced-by-count":0,"title":["More Than Five Years of Sustained Remission With Mepolizumab in Adolescent-Onset Eosinophilic Granulomatosis With Polyangiitis: A Case Report"],"prefix":"10.7759","author":[{"given":"Tomoyuki","family":"Araya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiyuki","family":"Kita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tasuku","family":"Iwabuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Higashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Hara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kez570","article-title":"Eosinophilic granulomatosis with polyangiitis: understanding the disease and its management","volume":"59","author":"Trivioli G","year":"2020","unstructured":"Trivioli G, Terrier B, Vaglio A. Eosinophilic granulomatosis with polyangiitis: understanding the disease and its management. Rheumatology (Oxford). 2020, 59:iii84-94. 10.1093\/rheumatology\/kez570","journal-title":"Rheumatology (Oxford)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00097-2016","article-title":"Respiratory manifestations of eosinophilic granulomatosis with polyangiitis (Churg-Strauss)","volume":"48","author":"Cottin V","year":"2016","unstructured":"Cottin V, Bel E, Bottero P, et al.. Respiratory manifestations of eosinophilic granulomatosis with polyangiitis (Churg-Strauss). Eur Respir J. 2016, 48:1429-41. 10.1183\/13993003.00097-2016","journal-title":"Eur Respir J"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1702079","article-title":"Mepolizumab or placebo for eosinophilic granulomatosis with polyangiitis","volume":"376","author":"Wechsler ME","year":"2017","unstructured":"Wechsler ME, Akuthota P, Jayne D, et al.. Mepolizumab or placebo for eosinophilic granulomatosis with polyangiitis. N Engl J Med. 2017, 376:1921-32. 10.1056\/NEJMoa1702079","journal-title":"N Engl J Med"},{"key":"ref4","unstructured":"Nanbyo Information Center. Eosinophilic granulomatosis with polyangiitis (designated intractable disease No. 45). (2025). Accessed. November 30, 2025: https:\/\/www.nanbyou.or.jp\/entry\/3878."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780330806","article-title":"The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis)","volume":"33","author":"Masi AT","year":"1990","unstructured":"Masi AT, Hunder GG, Lie JT, et al.. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum. 1990, 33:1094-100. 10.1002\/art.1780330806","journal-title":"Arthritis Rheum"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2021-221794","article-title":"2022 American College of Rheumatology\/European Alliance of Associations for Rheumatology Classification Criteria for eosinophilic granulomatosis with polyangiitis","volume":"81","author":"Grayson PC","year":"2022","unstructured":"Grayson PC, Ponte C, Suppiah R, et al.. 2022 American College of Rheumatology\/European Alliance of Associations for Rheumatology Classification Criteria for eosinophilic granulomatosis with polyangiitis. Ann Rheum Dis. 2022, 81:309-14. 10.1136\/annrheumdis-2021-221794","journal-title":"Ann Rheum Dis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.101279","article-title":"Modification and validation of the Birmingham Vasculitis Activity Score (version 3)","volume":"68","author":"Mukhtyar C","year":"2009","unstructured":"Mukhtyar C, Lee R, Brown D, et al.. Modification and validation of the Birmingham Vasculitis Activity Score (version 3). Ann Rheum Dis. 2009, 68:1827-32. 10.1136\/ard.2008.101279","journal-title":"Ann Rheum Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0b013e318205a4c6","article-title":"The Five-Factor Score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) cohort","volume":"90","author":"Guillevin L","year":"2011","unstructured":"Guillevin L, Pagnoux C, Seror R, Mahr A, Mouthon L, Toumelin PL. The Five-Factor Score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) cohort. Medicine (Baltimore). 2011, 90:19-27. 10.1097\/MD.0b013e318205a4c6","journal-title":"Medicine (Baltimore)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaf256","article-title":"Glucocorticoids vs glucocorticoids plus cyclophosphamide in eosinophilic granulomatosis with polyangiitis without poor-prognosis factors: a target trial emulation study","volume":"64","author":"Sorin B","year":"2025","unstructured":"Sorin B, Papo M, Sinico RA, et al.. Glucocorticoids vs glucocorticoids plus cyclophosphamide in eosinophilic granulomatosis with polyangiitis without poor-prognosis factors: a target trial emulation study. Rheumatology (Oxford). 2025, 64:5238-44. 10.1093\/rheumatology\/keaf256","journal-title":"Rheumatology (Oxford)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab514","article-title":"Revisiting characteristics, treatment and outcome of cardiomyopathy in eosinophilic granulomatosis with polyangiitis (formerly Churg-Strauss)","volume":"61","author":"Sartorelli S","year":"2022","unstructured":"Sartorelli S, Chassagnon G, Cohen P, et al.. Revisiting characteristics, treatment and outcome of cardiomyopathy in eosinophilic granulomatosis with polyangiitis (formerly Churg-Strauss). Rheumatology (Oxford). 2022, 61:1175-84. 10.1093\/rheumatology\/keab514","journal-title":"Rheumatology (Oxford)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keae085","article-title":"Cardiac involvement in eosinophilic granulomatosis with polyangiitis: acute eosinophilic myocarditis and chronic inflammatory cardiomyopathy","volume":"64","author":"Liu X","year":"2025","unstructured":"Liu X, Zhou Y, Li J, et al.. Cardiac involvement in eosinophilic granulomatosis with polyangiitis: acute eosinophilic myocarditis and chronic inflammatory cardiomyopathy. Rheumatology (Oxford). 2025, 64:722-31. 10.1093\/rheumatology\/keae085","journal-title":"Rheumatology (Oxford)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/imj.12525","article-title":"Severe cardiomyopathy revealing antineutrophil cytoplasmic antibodies-negative eosinophilic granulomatosis with polyangiitis","volume":"44","author":"Bouiller K","year":"2014","unstructured":"Bouiller K, Samson M, Eicher JC, et al.. Severe cardiomyopathy revealing antineutrophil cytoplasmic antibodies-negative eosinophilic granulomatosis with polyangiitis. Intern Med J. 2014, 44:928-31. 10.1111\/imj.12525","journal-title":"Intern Med J"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.858344","article-title":"Case report: severe eosinophilic asthma associated with anca-negative egpa in a young adult successfully treated with benralizumab","volume":"13","author":"Ricciardi L","year":"2022","unstructured":"Ricciardi L, Soler DG, Bennici A, Brunetto S, Pioggia G, Gangemi S. Case report: severe eosinophilic asthma associated with anca-negative egpa in a young adult successfully treated with benralizumab. Front Pharmacol. 2022, 13:858344. 10.3389\/fphar.2022.858344","journal-title":"Front Pharmacol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/446586-more-than-five-years-of-sustained-remission-with-mepolizumab-in-adolescent-onset-eosinophilic-granulomatosis-with-polyangiitis-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T03:45:52Z","timestamp":1766029552000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/446586-more-than-five-years-of-sustained-remission-with-mepolizumab-in-adolescent-onset-eosinophilic-granulomatosis-with-polyangiitis-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,17]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.99496","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,17]]}}}